Absolute Return Capital’s Exact Sciences EXAS Stock Holding History

Absolute Return Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-33,116	Closed	-$564K	–	723
2014 Q2	$564K	Buy	33,116 +1,060	+3%	+$14.6K	0.01%	814
2014 Q1	$454K	Buy	+32,056	New	+$433K	0.01%	873

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Absolute Return Capital's EXAS Position: Q3 2014 in Review

Absolute Return Capital sold out of Exact Sciences (EXAS) in Q3 2014, closing a stake of 33,116 shares — an estimated $564K sold.

Absolute Return Capital first reported a position in EXAS in Q1 2014 and held it in 2 quarters. The position peaked at $564K in Q2 2014. 175 funds tracked by Wall St. Rank hold EXAS as of Q3 2014.

Absolute Return Capital reported no remaining Exact Sciences position as of Q3 2014 after selling out during the quarter.
Absolute Return Capital sold 33,116 Exact Sciences shares in Q3 2014, an estimated $564K.
Absolute Return Capital first reported a position in Exact Sciences in Q1 2014 and held it in 2 quarters.
Absolute Return Capital's Exact Sciences position peaked at $564K in Q2 2014.
175 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2014.

Based on Absolute Return Capital's 13F filing for Q3 2014, filed 14 Nov 2014.